{"nct_id":"NCT02586987","title":"A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours","status":"COMPLETED","status_verified_date":"2019-11","start_date":"2015-12-28","start_date_type":"ACTUAL","primary_completion_date":"2018-07-25","primary_completion_date_type":"ACTUAL","completion_date":"2019-09-20","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AZN"]}